- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT07624266
Comparison of First and Second Capillary Blood Drops for Blood Glucose Measurement
31. maj 2026 opdateret af: Ayten Kaya, Ordu University
Comparison of Capillary Blood Sampling Techniques for Blood Glucose Measurement in People With Diabetes: An Experimental Study
This study aimed to evaluate the effects of different capillary blood sampling techniques on blood glucose measurement results in people with diabetes.
Blood glucose measurements obtained from the first and second capillary blood drops after antiseptic application were compared.
In addition, measurements obtained with and without finger squeezing were evaluated.
The findings may contribute to improving standardization in capillary blood glucose monitoring procedures and reducing unnecessary repeated finger punctures in clinical practice.
Studieoversigt
Status
Afsluttet
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
This methodological and experimental study evaluated whether different capillary blood sampling techniques influence blood glucose measurement results in people with diabetes.
The study compared glucose measurements obtained from the first and second capillary blood drops and also evaluated measurements performed with and without finger squeezing under standardized clinical conditions.
The findings are expected to contribute to the standardization of capillary blood glucose monitoring procedures and improve clinical practice by reducing unnecessary repeated finger punctures and enhancing participant comfort.
Undersøgelsestype
Observationel
Tilmelding (Faktiske)
64
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiesteder
-
-
Ordu
-
Altinordu, Ordu, Tyrkiet (Türkiye), 52200
- Ordu Univercıty
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
- Voksen
- Ældre voksen
Tager imod sunde frivillige
Ingen
Prøveudtagningsmetode
Ikke-sandsynlighedsprøve
Studiebefolkning
Adults with diabetes who were hospitalized in the internal medicine clinics of a state hospital during the study period and met the study inclusion criteria.
Beskrivelse
Inclusion Criteria:
- Aged 18 years or older
- Diagnosed with diabetes mellitus
- Provided written and verbal informed consent to participate in the study
- Eligible for blood glucose measurement after at least 6 hours of fasting
- No condition preventing capillary blood sampling from the fingertip
- Physically and mentally able to undergo the measurement procedures specified in the study
Exclusion Criteria:
- Presence of a physical disability or deformity affecting fingertip blood glucose measurement
- Presence of coagulation disorders (e.g., hemophilia) or severe medical conditions affecting blood sampling
- Use of steroids within the previous 24 hours that could affect blood glucose levels
- Presence of physical or mental conditions limiting compliance with study procedures
- Inability or unwillingness to provide informed consent
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Difference between blood glucose measurements obtained with and without finger squeezing
Tidsramme: Day 1
|
Comparison of blood glucose values obtained from capillary blood samples collected with and without finger squeezing.
Blood glucose measurements were obtained consecutively during a single study visit (Day 1), first from a capillary blood sample collected without finger squeezing and subsequently from a capillary blood sample collected with finger squeezing during the same blood sampling and measurement session
|
Day 1
|
|
Difference between blood glucose values obtained from the first and second capillary blood drops following antiseptic application
Tidsramme: Day 1
|
Comparison of blood glucose values obtained from the first and second capillary blood drops after antiseptic application.
The first and second blood drop measurements were obtained consecutively during the same capillary blood sampling and measurement session.
|
Day 1
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Sponsor
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart (Faktiske)
1. februar 2025
Primær færdiggørelse (Faktiske)
30. juli 2025
Studieafslutning (Faktiske)
30. december 2025
Datoer for studieregistrering
Først indsendt
19. maj 2026
Først indsendt, der opfyldte QC-kriterier
31. maj 2026
Først opslået (Faktiske)
3. juni 2026
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
3. juni 2026
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
31. maj 2026
Sidst verificeret
1. maj 2026
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- 2024/212-BAEK239
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
INGEN
IPD-planbeskrivelse
Individual participant data will not be publicly available due to confidentiality and privacy considerations.
However, statistical data may be provided by the corresponding author upon reasonable request.
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Ingen
Studerer et amerikansk FDA-reguleret enhedsprodukt
Ingen
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .